Orthofix Medical Inc. provided earnings guidance for the year 2022. For the year, the company expects net sales to be in the range of $475.0 million to $490.0 million.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
14.57 USD | +0.62% | -5.20% | +8.09% |
05-09 | Orthofix Medical Inc. Announces FDA 510(K) Clearance for the Rodeo Telescopic Nail | CI |
05-08 | Roth MKM Upgrades Orthofix Medical to Buy From Neutral With $20 Price Target | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+8.09% | 543M | |
-4.77% | 179B | |
+4.10% | 113B | |
-3.85% | 67.88B | |
+5.19% | 52.03B | |
+5.54% | 43.3B | |
+6.16% | 41.79B | |
+23.81% | 32.49B | |
+16.25% | 25.65B | |
-5.06% | 24.55B |
- Stock Market
- Equities
- OFIX Stock
- News Orthofix Medical Inc.
- Orthofix Medical Inc. Provides Earnings Guidance for the Year 2022